Treatment with monoclonal anti-CD47 antibody can induce phagocytosis of macrophages in bladder cancer cells in vitro and significantly reduce tumor growth in bladder cancer xenografts in a dose-dependent manner in the recipient mice [32, 86]. The gene discussed is CD47; the disease is urinary bladder cancer.